For PFS, KEYTRUDA plus LENVIMA reduced the risk of disease progression or death by 61% (HR=0.39 [95% CI: 0.32-0.49]; p
(C) 2021 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.7 USD | +2.91% | +4.37% | +19.89% |
For PFS, KEYTRUDA plus LENVIMA reduced the risk of disease progression or death by 61% (HR=0.39 [95% CI: 0.32-0.49]; p
(C) 2021 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+19.89% | 322B | |
+24.17% | 562B | |
-6.33% | 358B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B | |
+2.07% | 117B |